Indazolyl sulphonamide derivatives useful as glucocorticoid modulators

US8030340B2 · kind B2 · utility

Assignees

• ASTRAZENECA AB · SE
• Bayer Schering Pharma AG · DE

Inventors

• Markus Berger · Berlin, DE
• Lena Kristina Bergstrom · Lund, SE
• Jan Dahmen · Lund, SE
• Anders Eriksson · Lund, SE
• Balint Gabos · Lund, SE
• Martin Hemmerling · Timrå, SE
• Krister Henriksson · Lund, SE
• Svetlana Ivanova · Lund, SE
• Matti Lepisto · Lund, SE
• Stinabritt Nilsson · Lund, SE
• Camilla Taflin · Lund, SE
• Hartmut Rehwinkel · Berlin, DE
• Darren McKerrecher · Macclesfield, GB

Key dates

• Filing date: Nov 21, 2007
• Grant date: Oct 4, 2011
• Expiry date: Nov 4, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D413/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of formula (I):or a pharmaceutically acceptable salt thereof, compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating the glucocorticoid receptor in a warm blooded animal).